Financials
Reported figures only · latest: Q2 2026
USD · US GAAP
EPS, diluted
$2.86
−43.5% vs same quarter last year
Net income by quarter
−$3.2M
−$1.1M
−$4.8M
−$1.9M
Q4 24 Q1 25 Q4 25 Q1 26
Source: SEC XBRL filings
· latest filing
The long view
Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income15 fiscal yearsShow the numbers
| Year | Revenue | Net income |
|---|
| FY25 | - | - |
|---|
| FY24 | - | - |
|---|
| FY23 | - | - |
|---|
| FY22 | - | - |
|---|
| FY21 | - | - |
|---|
| FY20 | $0 | - |
|---|
| FY19 | $0 | - |
|---|
| FY18 | $2M | −$9.9M |
|---|
| FY17 | $1.1M | −$12.3M |
|---|
| FY16 | $467K | −$17M |
|---|
| FY15 | $0 | −$10.6M |
|---|
| FY14 | $0 | −$9.1M |
|---|
| FY13 | - | −$17.5M |
|---|
| FY12 | - | −$3.1M |
|---|
| FY11 | - | - |
|---|
MarginsShare of revenueShow the numbers
| Year | Net margin |
|---|
| FY25 | - |
|---|
| FY24 | - |
|---|
| FY23 | - |
|---|
| FY22 | - |
|---|
| FY21 | - |
|---|
| FY20 | - |
|---|
| FY19 | - |
|---|
| FY18 | −483.6% |
|---|
| FY17 | −1133.5% |
|---|
| FY16 | −3630.2% |
|---|
| FY15 | - |
|---|
| FY14 | - |
|---|
| FY13 | - |
|---|
| FY12 | - |
|---|
| FY11 | - |
|---|
Free cash flowOperating cash flow minus capital expenditureShow the numbers
| Year | Free cash flow |
|---|
| FY25 | - |
|---|
| FY24 | - |
|---|
| FY23 | - |
|---|
| FY22 | −$18.5M |
|---|
| FY21 | −$32.9M |
|---|
| FY20 | −$26.3M |
|---|
| FY19 | −$14.9M |
|---|
| FY18 | −$9.1M |
|---|
| FY17 | −$12.1M |
|---|
| FY16 | −$12.1M |
|---|
| FY15 | −$8.6M |
|---|
| FY14 | −$10M |
|---|
| FY13 | −$2.5M |
|---|
| FY12 | −$3.1M |
|---|
| FY11 | - |
|---|
Net margin vs the sectorMedian of Healthcare companies filing with the SEC- EoCene Ltd.
- Healthcare median
Show the numbers
| Year | EoCene Ltd. | Healthcare median |
|---|
| FY25 | - | −30.6% |
|---|
| FY24 | - | −47% |
|---|
| FY23 | - | −58% |
|---|
| FY22 | - | −80.4% |
|---|
| FY21 | - | −71.9% |
|---|
| FY20 | - | −62.2% |
|---|
| FY19 | - | −46.3% |
|---|
| FY18 | −483.6% | −49.6% |
|---|
| FY17 | −1133.5% | −45.9% |
|---|
| FY16 | −3630.2% | −36% |
|---|
| FY15 | - | −38.4% |
|---|
| FY14 | - | −35.5% |
|---|
| FY13 | - | −37.1% |
|---|
| FY12 | - | −29.1% |
|---|
| FY11 | - | −27.9% |
|---|